Potency assay development uses DoE and QbD to improve accuracy, consistency, and regulatory readiness in biologics testing.

Accelerated drug development expertise. For small startups and academic spinoffs bringing their first molecules to market, ...

On May 6, the California Supreme Court will hear a case that could upend the economics of medical innovation.

The FDA rejected the promising skin cancer drug RP1 twice, leaving many puzzled and worried about what this means for other ...

Drug companies like Eli Lilly and Roche are racing to build supercomputers to help fix the 90% failure rate in drug ...

In the search for new drugs, artificial intelligence in the form of diffusion models is being used in drug design. What ...

ByteDance's drug unit showed an AI-designed IL-17 inhibitor at a Boston conference. The molecule targets interactions pharma called undruggable. Only trials will tell.

The FDA is testing real-time clinical trial reporting in an effort to speed up the drug review and approval process.

Hospitals filled to capacity. Case counts climbing by the hour. Quarantine became routine. It was the beginning of the ...

Bausch + Lomb CEO Brent Saunders joins 'Squawk on the Street' to discuss the impacts of artificial intelligence on healthcare ...

SHANGHAI, SHANGHAI, CHINA, April 30, 2026 /EINPresswire.com/ -- In today’s life sciences industry, moving a drug ...

Regulatory approval is a major milestone in the drug development process, but it is not the final chapter in the journey.